Nano-encapsulation of protein using an enteric polymer as carrier

IEE Proceedings Nanobiotechnology

Volumn 152, Issue 5, 2005, Pages 165-168

  Dupeyron D ^a   Gonzalez M ^b   Saez V ^c   Ramon J ^c   Rieumont, J ^d  

^a UNIVERSITY OF HAVANA   (Cuba)

^b Centro de Ingenieria e Investigaciones Quimicas   (Cuba)

^c CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^d Centro de Estudios de Productos Naturales   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMINE (BSA); ENTERIC POLYMER; NANO-ENCAPSULATION; PROTEIN DRUGS;

ELECTROPHORESIS; ENCAPSULATION; NANOTECHNOLOGY; POLYMERS; SAMPLING; TRANSMISSION ELECTRON MICROSCOPY;

PROTEINS;

BIOMATERIAL; BOVINE SERUM ALBUMIN; DRUG CARRIER; NANOMATERIAL; POLYGLACTIN;

ANIMAL; ARTICLE; CHEMISTRY; DIFFUSION; DRUG STABILITY; EVALUATION; HUMAN; INTESTINE; MATERIALS TESTING; METHODOLOGY; NANOTECHNOLOGY; PARTICLE SIZE; ULTRASTRUCTURE;

ANIMALS; COATED MATERIALS, BIOCOMPATIBLE; DIFFUSION; DRUG CARRIERS; DRUG STABILITY; HUMANS; INTESTINES; MATERIALS TESTING; NANOSTRUCTURES; NANOTECHNOLOGY; PARTICLE SIZE; POLYGLACTIN 910; SERUM ALBUMIN, BOVINE;

EID: 27144492108     PISSN: 14781581     EISSN: None     Source Type: Journal    
DOI: 10.1049/ip-nbt:20050005     Document Type: Conference Paper

References (21)

1. Kawashima, Y.: 'Nanoparticulate systems for improved drug delivery', Advanced Drug Delivery Review, 2001, 47, pp. 1-2
2. Soppimath, K.S., Aminabhavi, T.M., Kulkarni, A.R., and Rudzinski, W.E.: 'Biodegradable polymeric nanoparticles as drug delivery devices' 2001, 70, pp. 1-20
3. Majeti, N.V., and Kumar, R.: 'Nano and microparticles as controlled drug delivery devices', Journal Pharm Pharmaceut Sci., 2000, 2, pp. 234-258
4. Vachon, M.G., and Nairn, J.G.: 'Physico- chemical evaluation of acetylsalicylic acid-Eudragit RS100 microspheres prepared using a solvent-partition method', Journal of Microencapsulation, 1995, 12, (3), pp. 287-305
5. Carino, G.P., Jacob, J.S., and Mathiowitz, E.: 'Nanosphere based insulin delivery', Journal of Controlled Release, 2000, 65, pp. 261-269
6. Mesiha, M., Plakpgianms, F., and Vejosoth, S.: 'Enhanced oral absorption of insulin from desolvated fatty acid - sodium glycocholate emulsions', Int. J. Pharm, 1994, 23, (1), pp. 213-216
7. Fasano, A., and Uzza, S.: 'Modulation of intestinal tight junctions by zona occludens toxin permits enteral administration of insulin and other macromolecular in animal model', J. Clin Invest. 1997, 99, pp. 1158-1164
8. Yamamoto, A. et al.: 'Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats', Pharm Res. 1994, 11, pp. 1496-1500
9. Morishita, M., Morishita, I., Takayama, K., Machida, Y., and Nagai, T.: 'Site-dependent effect of aprotinin, sodium caprate. Na2 EDTA and sodium glycolcholate on the intestinal absorption of insulin', Biol. Pharm. Bull. 1993, pp. 68-72
10. Touitou, E., and Rubinstein, A.: Targeted enteral delivery of insulin to rats', Int. J. Pharmaceut, 1986, pp. 95-99
11. Morishita, M., Morishita, I., Takayama, K., Machida, Y., and Nagai, T.: 'Enteral insulin delivery by microspheres in three different formulations using Eudragit L 100 and S 100', Int. J. Pharm. 1993, pp. 29-37
12. Gwinnup, G., Elias, A.N., and Domurat, E.S.: 'Insulin and C-peptide levels following oral administration of insulin in intestinal - enzyme protected capsules', Gen. Pharmac, 1991, 22, pp. 243-246
13. Damge, C., Michael, C., Aprahamian, M., Couvreur, P., and Devissaguet, J.P.: 'Advantage of e neww colloidal grug delivery system in the insulin treatment of Streptozotcin - induced diabetic-rats', Diabetologica, 1986, 29, p. 531A
14. Couvreur, P., Lenaerts, V., Kante, B., Roland, M., and Speiser, P.: 'Oral and parenteral administration of insulin associated to hydrolysable nanoparticles', Acta Pharm. Technol., 1980, 26, pp. 220-222
15. Shen, W.C.: 'Oral peptide and protein delivery: Unfulfilled promise?', Drug Discovery Today, 2003, 8, (14), pp. 607-608
16. Ferrero, C., Bravo, I., and Jiménez, M.R.: 'Drug release kinetics and fronts movements studies from methyl methacrylate (MMA) copolymer matrix tablets: effect of copolymer type and matrix porosity', Journal of Controlled Release. 2003, 92, pp. 69-82
17. Li, J.K., Wang, N., and Wu, X.S.: 'A novel biodegradable systems based on gelatin nanoparticles and Poly (lactic-co- glycolic acid) microspheres for protein and peptide drug delivery'. Journal of Pharmaceutical Sciences, 1997, 86, (8), pp. 891-895
18. Péan, J.M., Venier-Juliene, M.C., Filmon, R., Sergent, M., Phan-Tan, R., and Benoit, J.P.: 'Optimization of HSA and encapsulation yields in PLGA microparticles', International Journal of Pharmaceutics, 1998, 166, pp. 105-115
19. Lopes, M.J., and Ferreira, J.M.M.: 'Microparticles for delivering therapeutic peptides and protein to the lumen of small intestine', European Journal of Pharmaceutics and Biopharmaceutics, 2001, 52, pp. 39-44
20. Laemmli, U.K.: 'Cleavage of structural protein during assembly of the head bacteriophage T4', Nature, 1970, 227, pp. 680-685
21. Silva, J.P.S., and Ferreira, J.P.M.: 'Effect of drug properties on the release from CAP microspheres prepared by a solvent evaporation method', J. Microencapsulation, 1999, 16, pp. 95-103